COVID-19 -- Worldwide/Unknown
The meta-analysis of the 3 corticosteroid trials published today, plus 4 other such trials, showed that 28-day rates of death from any cause were lower in COVID-19 patients given corticosteroids than in those given usual care or a placebo. The study, conducted by the World Health Organization (WHO) Rapid Evidence Appraisal for COVID-19 Therapies (REACT) investigators, analyzed data from 1703 patients enrolled in the trials.
A total of 3 trials each in the meta-analysis involved
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?7743273&promed&0
No comments:
Post a Comment